Josephine M. Forbes Australian scientist
Forbes, Josephine.
Forbes, Josephine 1970-
VIAF ID: 163181392 (Personal)
Permalink: http://viaf.org/viaf/163181392
Preferred Forms
-
100 1 _ ‡a Forbes, Josephine
-
100 1 _ ‡a Forbes, Josephine
-
-
100 1 _ ‡a Forbes, Josephine
-
100 1 _ ‡a Forbes, Josephine ‡d 1970-
-
-
100 0 _ ‡a Josephine M. Forbes ‡c Australian scientist
4xx's: Alternate Name Forms (6)
Works
Title | Sources |
---|---|
The effects of valsartan on the accumulation of circulating and renal advanced glycation end products in experimental diabetes. |
![]() |
Erratum: Once daily administration of the SGLT2 inhibitor, empagliflozin, attenuates markers of renal fibrosis without improving albuminuria in diabetic db/db mice |
![]() |
Genetic characterization of early renal changes in a novel mouse model of diabetic kidney disease |
![]() |
Globally elevating the AGE clearance receptor, OST48, does not protect against the development of diabetic kidney disease, despite improving insulin secretion |
![]() |
Glucose and glycogen in the diabetic kidney: Heroes or villains? |
![]() |
Glucose homeostasis can be differentially modulated by varying individual components of a western diet. |
![]() |
Glycaemic variability and its association with enteral and parenteral nutrition in critically ill ventilated patients |
![]() |
Glycemic control in diabetes is restored by therapeutic manipulation of cytokines that regulate beta cell stress |
![]() |
Going in Early: Hypoxia as a Target for Kidney Disease Prevention in Diabetes? |
![]() |
High-density lipoprotein modulates glucose metabolism in patients with type 2 diabetes mellitus |
![]() |
High glucose-induced impairment in insulin secretion is associated with reduction in islet glucokinase in a mouse model of susceptibility to islet dysfunction |
![]() |
Hypoxic human proximal tubular epithelial cells undergo ferroptosis and elicit an NLRP3 inflammasome response in CD1c+ dendritic cells |
![]() |
Impairment of Liver Glycogen Storage in the db/db Animal Model of Type 2 Diabetes: A Potential Target for Future Therapeutics? |
![]() |
Increased liver AGEs induce hepatic injury mediated through an OST48 pathway |
![]() |
Increased renal vascular endothelial growth factor and angiopoietins by angiotensin II infusion is mediated by both AT1 and AT2 receptors |
![]() |
Increased risk of cardiovascular disease in Type 1 diabetes: arterial exposure to remnant lipoproteins leads to enhanced deposition of cholesterol and binding to glycated extracellular matrix proteoglycans. |
![]() |
Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway |
![]() |
Insulin infusion reduces hepatocyte growth factor in lean humans. |
![]() |
Interactions between angiotensin II and NF-kappaB-dependent pathways in modulating macrophage infiltration in experimental diabetic nephropathy. |
![]() |
Interactions between renin angiotensin system and advanced glycation in the kidney. |
![]() |
Ischemic acute renal failure: Long-term histology of cell and matrix changes in the rat |
![]() |
Kidney disease risk factors do not explain impacts of low dietary protein on kidney function and structure |
![]() |
Macrophage and myofibroblast involvement in ischemic acute renal failure is attenuated by endothelin receptor antagonists |
![]() |
The Maillard reaction : interface between aging, nutrition and metabolism |
![]() ![]() ![]() ![]() |
The maillard reaction / Merlin C Thomas, Josephine Forbes. - Cambridge, 2010. |
![]() ![]() |
Mapping time-course mitochondrial adaptations in the kidney in experimental diabetes |
![]() |
Mechanisms of diabetic complications. |
![]() |
Methylglyoxal, cognitive function and cerebral atrophy in older people. |
![]() |
Methylglyoxal modification of Nav1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy |
![]() |
Mitochondria-Power Players in Kidney Function? |
![]() |
MKK3 signalling plays an essential role in leukocyte-mediated pancreatic injury in the multiple low-dose streptozotocin model |
![]() |
Modulation of nephrin in the diabetic kidney: association with systemic hypertension and increasing albuminuria |
![]() |
Novel therapeutics for diabetic micro- and macrovascular complications. |
![]() |
Nox-4 deletion reduces oxidative stress and injury by PKC-α-associated mechanisms in diabetic nephropathy |
![]() |
Obesity-induced renal impairment is exacerbated in interleukin-6-knockout mice |
![]() |
Oxidative stress as a major culprit in kidney disease in diabetes |
![]() |
Perinatal exposure to high dietary advanced glycation end products in transgenic NOD8.3 mice leads to pancreatic beta cell dysfunction. |
![]() |
The physiological deadlock between AMPK and gluconeogenesis: SOGA, a novel protein, may provide the key. |
![]() |
Plasma advanced glycation end products (AGEs) and NF-κB activity are independent determinants of diastolic and pulse pressure. |
![]() |
The pleiotropic actions of rosuvastatin confer renal benefits in the diabetic Apo-E knockout mouse. |
![]() |
Preservation of kidney function with combined inhibition of NADPH oxidase and angiotensin-converting enzyme in diabetic nephropathy. |
![]() |
Prolyl hydroxylase inhibitors: a breath of fresh air for diabetic kidney disease? |
![]() |
RAGE Deletion Confers Renoprotection by Reducing Responsiveness to Transforming Growth Factor-β and Increasing Resistance to Apoptosis. |
![]() |
RAGE-induced cytosolic ROS promote mitochondrial superoxide generation in diabetes. |
![]() |
Ramipril inhibits AGE-RAGE-induced matrix metalloproteinase-2 activation in experimental diabetic nephropathy |
![]() |
Ramipril prevents microtubular changes in proximal tubules from streptozotocin diabetic rats. |
![]() |
Receptor for advanced glycation end-products (RAGE) provides a link between genetic susceptibility and environmental factors in type 1 diabetes. |
![]() |
Receptor for AGEs (RAGE) blockade may exert its renoprotective effects in patients with diabetic nephropathy via induction of the angiotensin II type 2 (AT2) receptor. |
![]() |
Reduced tubular cation transport in diabetes: prevented by ACE inhibition |
![]() |
The relationship between heat shock protein 72 expression in skeletal muscle and insulin sensitivity is dependent on adiposity. |
![]() |
Renal connective tissue growth factor induction in experimental diabetes is prevented by aminoguanidine |
![]() |
Renal microvascular injury in diabetes: RAGE and redox signaling. |
![]() |
Reply |
![]() |
Report on ISN Forefronts, Melbourne, Australia, 4-7 October 2012: tubulointerstitial disease in diabetic nephropathy |
![]() |
Response to Letter: Advanced glycation end products and esRAGE are associated with bone turnover and incidence of hip fracture in older men |
![]() |
Reversible Angiotensin II-Mediated Albuminuria in Rat Kidneys Is Dynamically Associated with Cytoskeletal Organization |
![]() |
The role of advanced glycation in reduced organic cation transport associated with experimental diabetes |
![]() |
Rosiglitazone attenuates atherosclerosis in a model of insulin insufficiency independent of its metabolic effects |
![]() |
SaO035SYNBIOTIC THERAPY IN PRE-DIALYSIS: A RANDOMISED CONTROLLED TRIAL |
![]() |
Serum 25-hydroxyvitamin D concentrations are associated with nuclear factor kappa-B activity but not with inflammatory markers in healthy normoglycemic adults. |
![]() |
Serum carboxymethyllysine concentrations are reduced in diabetic men with abdominal aortic aneurysms: Health In Men Study. |
![]() |
Stress in the kidney is the road to pERdition: is endoplasmic reticulum stress a pathogenic mediator of diabetic nephropathy? |
![]() |
Superior renoprotective effects of combination therapy with ACE and AGE inhibition in the diabetic spontaneously hypertensive rat. |
![]() |
Synbiotics Easing Renal Failure by Improving Gut Microbiology (SYNERGY): A Randomized Trial. |
![]() |
Tapping into Mitochondria to Find Novel Targets for Diabetes Complications |
![]() |
Targeted mitochondrial therapy using MitoQ shows equivalent renoprotection to angiotensin converting enzyme inhibition but no combined synergy in diabetes. |
![]() |
Targeting advanced glycation endproducts and mitochondrial dysfunction in cardiovascular disease. |
![]() |
Targeting advanced glycation with pharmaceutical agents: where are we now? |
![]() |
Targeting the AGE-RAGE axis improves renal function in the context of a healthy diet low in advanced glycation end-product content |
![]() |
Temporal Increases in Urinary Carboxymethyllysine Correlate with Albuminuria Development in Diabetes |
![]() |
Temporal renal expression of angiogenic growth factors and their receptors in experimental diabetes: role of the renin-angiotensin system. |
![]() |
Therapeutic interruption of advanced glycation in diabetic nephropathy: do all roads lead to Rome? |
![]() |
Transient Intermittent Hyperglycemia Accelerates Atherosclerosis by Promoting Myelopoiesis |
![]() |
Type 2 diabetes, skin autofluorescence, and brain atrophy. |
![]() |
Ubiquinone (coenzyme Q10) prevents renal mitochondrial dysfunction in an experimental model of type 2 diabetes |
![]() |
Vascular complications in diabetes: old messages, new thoughts |
![]() |
প্রত্যুত্তর |
![]() |